Aarti Drugs Limited released its Q1 results on Friday and reported a 38.8% surge in the net consolidated profits from ₹34.8 crore to ₹48 crore, it said in a stock regulatory filing. Among other things, the firm said that the board of directors of the company has approved buyback not exceeding 6,65,000 fully paid-up equity shares for ₹900 per equity …
